Notes
National Health Service
Reference
NICE. NICE says drug to treat Batten disease cannot be recommended for NHS use because company is unable to address concerns about long-term effectiveness . Internet Document : 22 Feb 2019. Available from: URL: https://www.nice.org.uk/news/article/nice-says-drug-to-treat-batten-disease-cannot-be-recommended-for-nhs-use-because-company-is-unable-to-address-concerns-about-long-term-effectiveness
Rights and permissions
About this article
Cite this article
Cerliponase alfa not recommended by NICE for Batten disease. PharmacoEcon Outcomes News 823, 9 (2019). https://doi.org/10.1007/s40274-019-5699-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5699-7